Posted: Nov 27, 2017
The government and the life sciences sector have agreed a multi-billion-pound deal, ensuring that the UK remains at the forefront of innovation in this sector.
The Sector Deal will help ensure new pioneering treatments and medical technologies are produced in the UK, improving patient lives and driving economic growth. The deal involves substantial investment from private and charitable sectors and significant commitments in research and development from the government.
The sector is highly productive, and export focused, generating £64 billion of turnover and employing over 233,000 scientists and staff. The UK is home to world-leading companies such as GSK and AstraZeneca, a strong small and medium-sized business sector, major health charities such as the Wellcome Trust and Cancer Research UK, and the NHS.
The Sector Deal builds on the , which was led by the sector and Professor Sir John Bell.
Published by Gov.UK